Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Sentman

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
European Journal of Immunology|September 1, 2005
Control of murine gammaherpesvirus infection is independent of NK cellsEdward J Usherwood, Sarah K Meadows, Sarah G Crist, et al.
Frontiers in Immunology|June 1, 2016
Signaling in Effector Lymphocytes: Insights toward Safer ImmunotherapyKamalakannan Rajasekaran, Matthew J Riese, Sridhar Rao, et al.
Elife|December 5, 2017
Computationally-driven identification of antibody epitopesCasey K Hua, Albert T Gacerez, Charles L Sentman, et al.
Nature Biotechnology|December 16, 2014
Biopolymer implants enhance the efficacy of adoptive T-cell therapySirkka B Stephan, Alexandria M Taber, Ilona Jileaeva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
TLRs mediate IFN-gamma production by human uterine NK cells in endometriumMikael Eriksson, Sarah K Meadows, Satarupa Basu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2015
B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor ImmunityMing-Ru Wu, Tong Zhang, Albert T Gacerez, et al.
Cancer Immunology, Immunotherapy : CII|May 28, 2021
Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30Savannah E Butler, Rachel A Brog, Cheryl H Chang, et al.
Cancer Immunology, Immunotherapy : CII|September 25, 2007
Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor modelMelissa A Barber, Tong Zhang, Bethany A Gagne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interfaceSatyan S Kalkunte, Teddy F Mselle, Wendy E Norris, et al.
Transfusion|January 23, 2014
The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cellsLaleh Talebian, Dawn A Fischer, Jillian Wu, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
European Journal of Immunology|September 1, 2005
Control of murine gammaherpesvirus infection is independent of NK cellsEdward J Usherwood, Sarah K Meadows, Sarah G Crist, et al.
Frontiers in Immunology|June 1, 2016
Signaling in Effector Lymphocytes: Insights toward Safer ImmunotherapyKamalakannan Rajasekaran, Matthew J Riese, Sridhar Rao, et al.
Elife|December 5, 2017
Computationally-driven identification of antibody epitopesCasey K Hua, Albert T Gacerez, Charles L Sentman, et al.
Nature Biotechnology|December 16, 2014
Biopolymer implants enhance the efficacy of adoptive T-cell therapySirkka B Stephan, Alexandria M Taber, Ilona Jileaeva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
TLRs mediate IFN-gamma production by human uterine NK cells in endometriumMikael Eriksson, Sarah K Meadows, Satarupa Basu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2015
B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor ImmunityMing-Ru Wu, Tong Zhang, Albert T Gacerez, et al.
Cancer Immunology, Immunotherapy : CII|May 28, 2021
Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30Savannah E Butler, Rachel A Brog, Cheryl H Chang, et al.
Cancer Immunology, Immunotherapy : CII|September 25, 2007
Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor modelMelissa A Barber, Tong Zhang, Bethany A Gagne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interfaceSatyan S Kalkunte, Teddy F Mselle, Wendy E Norris, et al.
Transfusion|January 23, 2014
The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cellsLaleh Talebian, Dawn A Fischer, Jillian Wu, et al.
Pageof 8